Compared to CD38+ primitive cells, CD38 dim/− primitive cells have greater differentiation potential, lower reactivity to growth factor stimulation, and have long been considered as leukemia stem cells (LSCs) associated with leukemia [27]. This evidence concerns the gene CD38 and leukemia.